FDA announces recall of some liquid pharmaceutical products

August 16, 2017

(HealthDay)—The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in vulnerable patients.

The drugs and dietary supplements, made by PharmaTech LLC in Davie, Fla., include liquid stool softeners, liquid vitamin D drops and liquid multivitamins marketed for infants and children, the agency said in a news release.

Reports of the discovery of Burkholderia cepacia bacteria in both Diocto Liquid and Diocto Syrup prompted the voluntary recall by three companies that label PharmaTech products, the FDA said. The three companies are Rugby Laboratories, Major Pharmaceuticals and Leader Brands.

"B. cepacia poses a serious threat to vulnerable patients, including infants and young children who still have developing immune systems," FDA Commissioner Dr. Scott Gottlieb said in a statement.

"These products were distributed nationwide to retailers, , pharmacies and sold online—making it important that parents, patients and be made aware of the potential risk and immediately stop using these products," Gottlieb added.

The bacteria pose the greatest danger to hospitalized patients, and people with health problems such as and chronic lung diseases, according to the U.S. Centers for Disease Control and Prevention.

Signs of infection can range from no symptoms at all to serious respiratory infections, the CDC said. The bacteria can spread from person to person by direct contact and is often resistant to common antibiotics.

The FDA advises patients and physicians to stop using these products immediately. Consumers with questions can contact Rugby Laboratories/Major Pharmaceuticals at 800-645-2158, or Leader at 800-200-6313.

Explore further: Infectious outbreak in critically ill children leads to recall of contaminated medication

More information: SOURCE: U.S. Food and Drug Administration, news release, Aug. 11, 2017

Here is the FDA's complete list of the recalled products.

Related Stories

Infectious outbreak in critically ill children leads to recall of contaminated medication

February 9, 2017
Infection prevention and control experts at Texas Children's Hospital halted a 24-patient outbreak of Burkholderia cepacia in critically ill children after identifying docusate, a liquid stool softener, as the underlying ...

FDA will target e-cigs in health campaign for youth

August 8, 2017
(HealthDay)—The U.S. Food and Drug Administration will now include electronic cigarettes in a public health education campaign to discourage American youth from using tobacco and nicotine products.

Antibiotics are not always the answer

July 7, 2017
The discovery of penicillin in 1928 was heralded as a medical miracle. As one of the first antibiotics, it could cure patients of potentially deadly bacterial illnesses, such as scarlet fever, typhoid and pneumonia.

FDA: Ameridose issues voluntary recall of all products

November 2, 2012
(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release ...

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.